Detecting Early-Stage Cancer with ctDNA: Early Awareness, Easier Treatment

Medical Service

Home / Medical Service / Innovation Check Up / Detecting Early-Stage Cancer with ctDNA: Early Awareness, Easier Treatment

Detecting Early-Stage Cancer with ctDNA: Early Awareness, Easier Treatment

Cancer is known as a “silent threat” because many people are unaware it is developing in their bodies. In its early stages, cancer often presents no noticeable symptoms. As a result, many patients are only diagnosed once the disease has progressed to an advanced stage, making treatment more complex, reducing the chances of recovery, and significantly increasing medical costs.

According to the World Health Organization (WHO), cancer-related deaths are expected to rise by more than 45% by 2030. Currently, over 70% of patients are diagnosed at late stages of the disease, which lowers survival rates and treatment effectiveness. This highlights the critical importance of early detection, which offers the best opportunity for effective treatment and improved survival.

Why Is Early Detection So Important?

Increased survival rates: Patients diagnosed at an early stage have survival rates as high as 90–95%.
Simplified treatment: Early-stage treatment often involves less invasive approaches, such as minor surgery or targeted therapies.
Lower long-term costs: Advanced-stage cancer treatment usually requires extensive resources, resulting in high medical and follow-up expenses.
Better quality of life: Patients who receive treatment early tend to maintain stronger physical and mental health.

What Is ctDNA Testing?

ctDNA (Circulating Tumor DNA) testing is a blood-based cancer screening method that detects genetic material from cancer cells circulating in the bloodstream. Using advanced Next-generation sequencing (NGS) technology, ctDNA testing can simultaneously identify mutations linked to multiple types of cancer. This enables early detection of abnormalities and helps determine specific cancer risks—without the need for surgery or tissue biopsy.

Types of Cancer Detectable by ctDNA Screening ctDNA testing can identify risks for up to 10 major cancers, including:

Lung cancer
Breast cancer
Colorectal cancer
Gastric cancer
Liver and bile duct cancer
Pancreatic cancer
Ovarian cancer
Esophageal cancer
Endometrial cancer
Head and neck cancer

Advantages of ctDNA Testing

Minimally invasive: Requires only a single blood draw, yet screens for multiple cancers at once.
Convenient: No need for surgical biopsies or complex procedures.
High accuracy: Specificity of 95.9% and sensitivity of 78.1%.
Quick results: Available within 30 days.

Advantages of ctDNA Testing

Minimally invasive: Requires only a single blood draw, yet screens for multiple cancers at once.
Convenient: No need for surgical biopsies or complex procedures.
High accuracy: Specificity of 95.9% and sensitivity of 78.1%.
Quick results: Available within 30 days.

Important Consideration

ctDNA testing is designed only for individuals who have never been diagnosed with cancer and who show no current symptoms or warning signs of the disease.

A Step Toward Lifelong Health

Cancer does not wait for the right time. Early screening is the most valuable investment in life and health. ctDNA represents a breakthrough innovation that empowers us to “know sooner, prevent earlier, and improve survival rates.”

CALL US : 02 651 5988

Medical Service

Detecting Early-Stage Cancer with ctDNA: Early Awareness, Easier Treatment

Detecting Early-Stage Cancer with ctDNA: Early Awareness, Easier Treatment